About the Author
Alcides is a Cell Bio graduate, finishing a PhD in Neuroscience. Writes about life sciences, pharma, and biotech.

Neuralink presents LINK V0.9
Elon Musk delivers on his promise.
By Alcides | 3 years ago

Provention Bio's novel diabetes treatment
Under looked biotech company might be near tipping point
By Alcides | 3 years ago

Novo Nordisk in the expanding market of diabetes care
The Danish multinational offers an exciting growth opportunity.
By Alcides | 3 years ago

The COVID-19 vaccine market will not be a winner-takes-all
The US government has selected three vaccine candidates to fund their Phase 3 trials through Operation Warp Speed.
By Alcides | 3 years ago